SourceOne Global Partners has initiated a double-blind, placebo-controlled, randomized study on its proprietary cardiovascular wellness compound, Sytrinol. In addition to further validating the benefits of Sytrinol as a stand-alone compound, this study will include several arms with a combination of Sytrinol and plant sterols to further illuminate the strength of efficacy of these compounds as a compelling and potent combination dietary supplement. The study will be conducted by Radiant Research, Inc.